1. Al-Aly Z: The new role of calcimimetics as vasculotropic agents.
Kidney Int 2009; 75 (1): 9-12
2. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D,
Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB:
Coronary-artery calcification in young adults with end-stage renal
disease who are undergoing dialysis. N Engl J Med 2000; 342 (20):
1478-1483
3. Block GA, Raggi P, Bellasi A, Kooienga L, Spiegel DM: Mortality
effect of coronary calcification and phosphate binder choice in
incident hemodialysis patients. Kidney Int 2007; 71 (5): 438-441
4. Garg AX, Clark WF, Haynes RB, House AA: Moderate renal
insufficiency and the risk of cardiovascular mortality: Results from
the NHANES I. Kidney Int 2002; 61 (4): 1486-1494
5. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic
kidney disease and the risks of death, cardiovascular events, and
hospitalization. N Engl J Med 2004; 351 (13): 1296-1305
6. Sarnak MJ: Cardiovascular complications in chronic kidney disease.
Am J Kidney Dis 2003; 41 (5 Suppl): 11-17
7. Shroff RC, McNair R, Skepper JN, Figg N, Schurgers LJ, Deanfield
J, Rees L, Shanahan CM: Chronic mineral dysregulation promotes
vascular smooth muscle cell adaptation and extracellular matrix
calcification. J Am Soc Nephrol 2010; 21 (1): 103-112
8. Byon CH, Javed A, Dai Q, Kappes JC, Clemens TL, Darley-Usmar
VM, McDonald JM, Chen Y: Oxidative stress induces vascular
calcification through modulation of the osteogenic transcription
factor Runx2 by AKT signaling. J Biol Chem 2008; 283 (22):
15319-15327
9. Al-Aly Z: Arterial calcification: A tumor necrosis factor-alpha
mediated vascular Wnt-opathy. Transl Res 2008; 151 (5): 233-239
10. Dellegrottaglie S, Sanz J, Rajagopalan S: Molecular determinants
of vascular calcification: A bench to bedside view. Curr Mol Med
2006; 6 (5): 515-524
11. Turkmen K, Gorgulu N, Uysal M, Ozkok A, Sakaci T, Unsal A,
Yildiz A: Fetuin-A, inflammation, and coronary artery calcification
in hemodialysis patients. Indian J Nephrol 2011; 21 (2): 90-94
12. London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda
H: Arterial media calcification in end-stage renal disease: Impact
on all-cause and cardiovascular mortality. Nephrol Dial Transplant
2003; 18 (9): 1731-1740
13. Hermans MM, Brandenburg V, Ketteler M, Kooman JP, van der
Sande FM, Gladziwa U, Rensma PL, Bartelet K, Konings CJ,
Hoeks AP, Floege J, Leunissen KM: Study on the relationship of
serum fetuin-A concentration with aortic stiffness in patients on
dialysis. Nephrol Dial Transplant 2006; 21 (5): 1293-1299
14. Wang AY, Woo J, Lam CW, Wang M, Chan IH, Gao P, Lui SF, Li PK,
Sanderson JE: Associations of serum fetuin-A with malnutrition,
inflammation, atherosclerosis and valvular calcification syndrome
and outcome in peritoneal dialysis patients. Nephrol Dial Transplant
2005; 20 (8): 1676-1685
15. Ketteler M, Bongartz P, Westenfeld R, Wildberger JE, Mahnken
AH, Böhm R, Metzger T, Wanner C, Jahnen-Dechent W, Floege J:
Association of low fetuin-A (AHSG) concentrations in serum with
cardiovascular mortality in patients on dialysis: A cross-sectional
study. Lancet 2003; 361 (9360): 827-833
16. Stenvinkel P, Wang K, Qureshi AR, Axelsson J, Pecoits-Filho R,
Gao P, Barany P, Lindholm B, Jogestrand T, Heimbürger O, Holmes
C, Schalling M, Nordfors L: Low fetuin-A levels are associated with
cardiovascular death: Impact of variations in the gene encoding
fetuin. Kidney Int 2005; 67 (6): 2383-2392
17. Descamps-Latscha B, Herbelin A, Nguyen AT, Roux-Lombard P,
Zingraff J, Moynot A, Verger C, Dahmane D, de Groote D, Jungers P:
Balance between IL-1 beta, TNF-alpha, and their specific inhibitors
in chronic renal failure and maintenance dialysis. Relationships with
activation markers of T cells, B cells and monocytes. J Immunol
1995; 154 (2): 882-892
18. Canivet E, Lavaud S, Wong T, Guenounou M, Willemin JC, Potron
G, Chanard J: Cuprophane but not synthetic membrane induces
increases in serum tumor necrosis factor-alpha levels during
hemodialysis. Am J Kidney Dis 1994; 23 (1): 41-46
19. Tielemans C, Husson C, Schurmans T, Gastaldello K, Madhoun P,
Delville JP, Marchant A, Goldman M, Vanherweghem JL: Effects
of ultrapure and non-sterile dialysate on the inflammatory response
during in vitro hemodialysis. Kidney Int 1996; 49 (1): 236-243
20. Carrero JJ, Stenvinkel P: Persistent inflammation as a catalyst for
other risk factors in chronic kidney disease: A hypothesis proposal.
Clin J Am Soc Nephrol 2009; 4 Suppl 1: 49-55
21. Derici U, El Nahas AM: Vascular calcifications in uremia: Old
concepts and new insights. Semin Dial 2006; 19 (1): 60-68
22. Caliskan Y, Demirturk M, Ozkok A, Yelken B, Sakaci T, Oflaz H,
Unsal A, Yildiz A: Coronary artery calcification and coronary flow
velocity in haemodialysis patients. Nephrol Dial Transplant 2010;
25 (8): 2685-2690
23. Kirkpantur A, Altun B, Hazirolan T, Akata D, Arici M, Kirazli
S, Turgan C: Association among serum fetuin-A level, coronary
artery calcification, and bone mineral densitometry in maintenance
hemodialysis patients. Artif Organs 2009; 33 (10): 844-854
24. Sumida Y, Nakayama M, Nagata M, Nakashita S, Suehiro T,
Kaizu Y, Ikeda H, Izumaru K: Carotid artery calcification and
atherosclerosis at the initiation of hemodialysis in patients with endstage
renal disease. Clin Nephrol 2010; 73 (5): 360-369
25. Jensky NE, Criqui MH, Wright MC, Wassel CL, Brody SA, Allison
MA: Blood pressure and vascular calcification. Hypertension 2010;
55 (4): 990-997
26. Matsuoka M, Iseki K, Tamashiro M, Fujimoto N, Higa N, Touma
T, Takishita S: Impact of high coronary artery calcification score
(CACS) on survival in patients on chronic hemodialysis. Clin Exp
Nephrol 2004; 8 (1): 54-58
27. Tamashiro M, Iseki K, Sunagawa O, Inoue T, Higa S, Afuso H,
Fukiyama K: Significant association between the progression of
coronary artery calcification and dyslipidemia in patients on chronic
hemodialysis. Am J Kidney Dis 2001; 38 (1): 64-69
Thank you for copying data from http://www.arastirmax.com
